AU1933697A - Method for assessing risk to develop psychotic disease - Google Patents

Method for assessing risk to develop psychotic disease

Info

Publication number
AU1933697A
AU1933697A AU19336/97A AU1933697A AU1933697A AU 1933697 A AU1933697 A AU 1933697A AU 19336/97 A AU19336/97 A AU 19336/97A AU 1933697 A AU1933697 A AU 1933697A AU 1933697 A AU1933697 A AU 1933697A
Authority
AU
Australia
Prior art keywords
assessing risk
psychotic disease
develop
develop psychotic
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19336/97A
Inventor
Maria Jesus Arranz
David Andrew Collier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605493.7A external-priority patent/GB9605493D0/en
Priority claimed from GBGB9605494.5A external-priority patent/GB9605494D0/en
Priority claimed from GBGB9607526.2A external-priority patent/GB9607526D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1933697A publication Critical patent/AU1933697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU19336/97A 1996-03-15 1997-03-12 Method for assessing risk to develop psychotic disease Abandoned AU1933697A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9605493 1996-03-15
GBGB9605493.7A GB9605493D0 (en) 1996-03-15 1996-03-15 Novel method
GBGB9605494.5A GB9605494D0 (en) 1996-03-15 1996-03-15 Novel method
GB9605494 1996-03-15
GB9607526 1996-04-11
GBGB9607526.2A GB9607526D0 (en) 1996-04-11 1996-04-11 Novel method
PCT/GB1997/000681 WO1997034928A1 (en) 1996-03-15 1997-03-12 Method for assessing risk to develop psychotic disease

Publications (1)

Publication Number Publication Date
AU1933697A true AU1933697A (en) 1997-10-10

Family

ID=27268182

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19336/97A Abandoned AU1933697A (en) 1996-03-15 1997-03-12 Method for assessing risk to develop psychotic disease

Country Status (2)

Country Link
AU (1) AU1933697A (en)
WO (1) WO1997034928A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO726897A0 (en) * 1997-06-10 1997-07-03 Garvan Institute Of Medical Research Method for assessing a predisposition to bipolar affective disorder
AU2001265268A1 (en) * 2000-06-01 2001-12-11 Pharmacia And Upjohn Company Mice heterozygous for wfs1 gene as mouse models for depression
WO2009036513A1 (en) * 2007-09-21 2009-03-26 Murdoch Childrens Research Institute Diagnostic and therapeutic protocols

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418162A (en) * 1991-10-22 1995-05-23 Duke University Serotonin transporter CDNA
AU7089896A (en) * 1995-09-23 1997-04-09 Medical Research Council Screening for disorders of serotonergic dysfunction

Also Published As

Publication number Publication date
WO1997034928A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
IL131710A0 (en) Method for maintaining replica consistency
AU2005897A (en) Methods for identifying human hereditary disease patterns
AU695664B2 (en) Method for treating cardiac inflammatory disease
AU1658897A (en) System for assessing bone characteristics
AU1630900A (en) Method for developing answer-options to issue-questions relating to child-development
ID17271A (en) PROCESS FOR CHANGE OF ETHYLBENZENA
ID20274A (en) PROCESS FOR PRODUCING DIAMINA
HUP0002062A3 (en) Method for diagnosing bone dysbolism
AU8105698A (en) Method for residual stress measuring
AU5251998A (en) Method of testing for periodontal disease
GB2321653B (en) Method for creping tissue
AU8346498A (en) Method for diagnosing alzheimer disease
AU3628595A (en) Screening method for periodontal disease
ID16751A (en) A PROCESS FOR MAKING PENTAERITOL
AU2546297A (en) Method for assessing disposable absorbent structures
AU7944398A (en) Method for determining the energy-information characteristics of a biological object
ID18917A (en) PROCESS FOR BENZOTIOFENA SYNTHESIS
AU9017098A (en) Method for diagnosing alzheimer's disease
AU3981799A (en) Method for identifying genes
ID15862A (en) PROCESS
AU1933697A (en) Method for assessing risk to develop psychotic disease
AU6509698A (en) Methods for clinical diagnosis
AU5652799A (en) Method for the diagnosis of cell proliferative disease
AU7558998A (en) Method for reinforcing
ID20955A (en) PROCESS FOR PRODUCING 7-OCTAN-1-AL